CMIC：2018年如何在日本成功进行临床试验白皮书（英文版）

There is no longer any excuse not to include Japan as an integral part of any globalclinical-development program for either pharmaceuticals or medical devices. With amore receptive climate for both starting and running trials, an improved infrastructurefor clinical research, and significant advances in accelerating drug approvals, Japan isnow firmly on the global development map.

There have always been strong reasons to secure a foothold in Japan. It is the world'sthird-largest sing